Serzone Settlement Pending: Bristol Would Pay “At Least” $70 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb is offering to pay "at least" $70 mil. to resolve product liability claims related to the antidepressant Serzone (nefazodone) under a proposed settlement awaiting approval in West Virginia federal court